These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 31281146

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
    Akyurek N, Uner A, Benekli M, Barista I.
    Cancer; 2012 Sep 01; 118(17):4173-83. PubMed ID: 22213394
    [Abstract] [Full Text] [Related]

  • 24. C-MYC and BCL2 translocation frequency in diffuse large B-cell lymphomas: A study of 97 patients.
    Akkaya B, Salim O, Akkaya H, Ozcan M, Yucel OK, Erdem R, Iltar U, Undar L.
    Indian J Pathol Microbiol; 2016 Sep 01; 59(1):41-6. PubMed ID: 26960633
    [Abstract] [Full Text] [Related]

  • 25. Impact of Double Expression of C-MYC/BCL2 Protein and Cell of Origin Subtypes on the Outcome among Patients with Diffuse Large B-Cell Lymphoma: a Single Asian Center Experience.
    Teoh CS, Lee SY, Chiang SK, Chew TK, Goh AS.
    Asian Pac J Cancer Prev; 2018 May 26; 19(5):1229-1236. PubMed ID: 29801406
    [Abstract] [Full Text] [Related]

  • 26. Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome.
    Caponetti GC, Dave BJ, Perry AM, Smith LM, Jain S, Meyer PN, Bast M, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Aoun P, Fu K, Greiner TC, Chan WC, Sanger WG, Weisenburger DD.
    Leuk Lymphoma; 2015 May 26; 56(11):3082-9. PubMed ID: 25827211
    [Abstract] [Full Text] [Related]

  • 27. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
    Testo N, Olson LC, Subramaniyam S, Hanson T, Magro CM.
    Am J Dermatopathol; 2016 Oct 26; 38(10):769-74. PubMed ID: 27391453
    [Abstract] [Full Text] [Related]

  • 28. Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL.
    Dunleavy K.
    Curr Treat Options Oncol; 2015 Dec 26; 16(12):58. PubMed ID: 26634708
    [Abstract] [Full Text] [Related]

  • 29. Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma.
    Oliveira CC, Maciel-Guerra H, Kucko L, Hirama EJ, Brilhante AD, Quevedo FC, da Cunha IW, Soares FA, Niero-Melo L, Dos Reis PP, Domingues MA.
    Diagn Pathol; 2017 Jan 07; 12(1):3. PubMed ID: 28061782
    [Abstract] [Full Text] [Related]

  • 30. A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients.
    Abdulla M, Laszlo S, Triumf J, Hedström G, Berglund M, Enblad G, Amini RM.
    Acta Oncol; 2016 Jan 07; 55(9-10):1126-1131. PubMed ID: 27549735
    [Abstract] [Full Text] [Related]

  • 31. High Frequency of Bone Marrow Involvement in Intravascular Large B-Cell Lymphoma.
    Wang J, Ding W, Gao L, Yao W, Chen M, Zhao S, Liu W, Zhang W.
    Int J Surg Pathol; 2017 Apr 07; 25(2):118-126. PubMed ID: 27553679
    [Abstract] [Full Text] [Related]

  • 32. Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma).
    Zeng D, Desai A, Yan F, Gong T, Ye H, Ahmed M, Nomie K, Romaguera J, Champlin R, Li S, Wang M.
    Am J Clin Oncol; 2019 Mar 07; 42(3):304-316. PubMed ID: 29419530
    [Abstract] [Full Text] [Related]

  • 33. Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma.
    Horn H, Ziepert M, Wartenberg M, Staiger AM, Barth TF, Bernd HW, Feller AC, Klapper W, Stuhlmann-Laeisz C, Hummel M, Stein H, Lenze D, Hartmann S, Hansmann ML, Möller P, Cogliatti S, Pfreundschuh M, Trümper L, Loeffler M, Glass B, Schmitz N, Ott G, Rosenwald A, DSHNHL16.
    Leukemia; 2015 Jul 07; 29(7):1564-70. PubMed ID: 25687653
    [Abstract] [Full Text] [Related]

  • 34. Double-Hit Large B Cell Lymphoma.
    Khelfa Y, Lebowicz Y, Jamil MO.
    Curr Oncol Rep; 2017 Sep 26; 19(11):74. PubMed ID: 28952038
    [Abstract] [Full Text] [Related]

  • 35. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP, Huang H, Gong LP, Wu Y, Xu HY, Zou Y, Lü BB, Zhong HS, Deng QQ, Xiao Q, Zeng ST, Zhu CD.
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec 26; 39(12):819-24. PubMed ID: 21215097
    [Abstract] [Full Text] [Related]

  • 36. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
    Tibiletti MG, Martin V, Bernasconi B, Del Curto B, Pecciarini L, Uccella S, Pruneri G, Ponzoni M, Mazzucchelli L, Martinelli G, Ferreri AJ, Pinotti G, Assanelli A, Scandurra M, Doglioni C, Zucca E, Capella C, Bertoni F.
    Hum Pathol; 2009 May 26; 40(5):645-52. PubMed ID: 19144384
    [Abstract] [Full Text] [Related]

  • 37. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
    Dupont T, Yang SN, Patel J, Hatzi K, Malik A, Tam W, Martin P, Leonard J, Melnick A, Cerchietti L.
    Oncotarget; 2016 Jan 19; 7(3):3520-32. PubMed ID: 26657288
    [Abstract] [Full Text] [Related]

  • 38. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
    Mationg-Kalaw E, Tan LH, Tay K, Lim ST, Tang T, Lee YY, Tan SY.
    Histopathology; 2012 Dec 19; 61(6):1214-8. PubMed ID: 23171357
    [Abstract] [Full Text] [Related]

  • 39. MYC, BCL2, and BCL6 expression as prognostic indicators in primary central nervous system lymphoma: A systematic review and meta-analysis.
    Ge L, Lu S, Xu L, Yan H.
    Clin Neurol Neurosurg; 2021 Sep 19; 208():106838. PubMed ID: 34339901
    [Abstract] [Full Text] [Related]

  • 40. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH.
    Am J Surg Pathol; 2013 Mar 19; 37(3):323-32. PubMed ID: 23348205
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.